retatrutide clinical trial results Reta data & dosing — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in Phase 3 trials for metabolic health — targeting GLP-1, GIP Triple hormone receptor agonist retatrutide

Can a patch really boost GLP-1 and cause noticeable weight loss

The suspected mechanism is glucagon activity: the glucagon receptor is expressed in certain tissues of the peripheral nervous system, and its chronic activation appears to alter neurosensory signaling in some subjects

- April 8, 2025 - AM-PR Building on a decade of research and validation, study leverages precision, phenotype-guided treatment for enhanced patient outcomes on GLP-1s

Perinatal risk factors for childhood obesity and metabolic dysregulation

As a member of the Medical and Scientific Communications team, Sandra educates healthcare professionals and consumers on nutrition, supplements, and related health concerns

GLP-1s Carry Lilly